Follow
Hussain Ali
Hussain Ali
Associate Professor at Quaid-i-Azam University Islamabad.
Verified email at qau.edu.pk
Title
Cited by
Cited by
Year
Nano-and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
EM Collnot, H Ali, CM Lehr
Journal of Controlled Release 161 (2), 235-246, 2012
2752012
Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer's disease
B Shal, W Ding, H Ali, YS Kim, S Khan
Frontiers in pharmacology 9, 548, 2018
1962018
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases
H Ali, B Weigmann, MF Neurath, EM Collnot, M Windbergs, CM Lehr
Journal of Controlled Release 183, 167-177, 2014
1402014
Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease
M Zeeshan, H Ali, S Khan, SA Khan, B Weigmann
International journal of pharmaceutics 558, 201-214, 2019
872019
Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model
F Leonard, H Ali, EM Collnot, BJ Crielaard, T Lammers, G Storm, CM Lehr
ALTEX: Alternatives to Animal Experimentation 29 (3), 275-85, 2012
832012
Antihyperalgesic properties of honokiol in inflammatory pain models by targeting of NF-κB and Nrf2 signaling
S Khalid, MZ Ullah, AU Khan, R Afridi, H Rasheed, A Khan, H Ali, YS Kim, ...
Frontiers in pharmacology 9, 140, 2018
822018
Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients in Islamabad, Pakistan
M Saqlain, A Riaz, MN Malik, S Khan, A Ahmed, S Kamran, H Ali
Medicina 55 (5), 163, 2019
802019
Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
H Ullah, A Khan, MW Baig, N Ullah, N Ahmed, MK Tipu, H Ali, S Khan
BMC complementary medicine and therapies 20, 1-14, 2020
782020
Budesonide loaded PLGA nanoparticles for targeting the inflamed intestinal mucosa—Pharmaceutical characterization and fluorescence imaging
H Ali, B Weigmann, EM Collnot, SA Khan, M Windbergs, CM Lehr
Pharmaceutical research 33, 1085-1092, 2016
762016
Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model
J Ali, AU Khan, FA Shah, H Ali, SU Islam, YS Kim, S Khan
Life Sciences 239, 116888, 2019
672019
Attenuation of inflammatory pain by puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators
MZ Ullah, AU Khan, R Afridi, H Rasheed, S Khalid, M Naveed, H Ali, ...
International immunopharmacology 61, 306-316, 2018
552018
Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression
H Ali, A Khan, J Ali, H Ullah, A Khan, H Ali, N Irshad, S Khan
BMC Pharmacology and Toxicology 21, 1-14, 2020
522020
Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-κβ pathway
E Sana, M Zeeshan, QU Ain, AU Khan, I Hussain, S Khan, E Lepeltier, ...
Nanomedicine 16 (10), 819-837, 2021
502021
Antinociceptive properties of 25‐methoxy hispidol A, a triterpinoid isolated from Poncirus trifoliata (Rutaceae) through inhibition of NF‐κB signalling in mice
A Khan, MZ Ullah, R Afridi, H Rasheed, S Khalid, H Ullah, H Ali, ...
Phytotherapy research 33 (2), 327-341, 2019
502019
Drug delivery to macrophages: A review of nano-therapeutics targeted approach for inflammatory disorders and cancer
M Mukhtar, H Ali, N Ahmed, R Munir, S Talib, AS Khan, R Ambrus
Expert Opinion on Drug Delivery 17 (9), 1239-1257, 2020
462020
Matrine alleviates neurobehavioral alterations via modulation of JNK-mediated caspase-3 and BDNF/VEGF signaling in a mouse model of burn injury
A Khan, B Shal, M Naveed, B Nasir, N Irshad, H Ali, S Khan
Psychopharmacology 237, 2327-2343, 2020
442020
Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators
S Khalid, A Khan, B Shal, H Ali, YS Kim, S Khan
Biomedicine & Pharmacotherapy 114, 108777, 2019
412019
Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling
A Khan, S Khan, H Ali, KU Shah, H Ali, O Shehzad, A Onder, YS Kim
International immunopharmacology 73, 451-460, 2019
392019
Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease
M Zeeshan, H Ali, S Khan, M Mukhtar, MI Khan, M Arshad
Nanomedicine 14 (15), 1945-1969, 2019
392019
A new cationic palladium (II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models
M Naveed, SZ Khan, S Zeeshan, A Khan, B Shal, A Atiq, H Ali, R Ullah, ...
Naunyn-Schmiedeberg's archives of pharmacology 392, 961-977, 2019
362019
The system can't perform the operation now. Try again later.
Articles 1–20